Catalyst Wire Dossier Catalyst Wire Dossier

Olaparib (Lynparza)

olaparib · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olaparib (Lynparza), covering 2025-07-10 to 2025-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy [Phase 3]

See pricing